These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32771236)

  • 21. Respiratory bacterial pathogen spectrum among COVID-19 infected and non-COVID-19 virus infected pneumonia patients.
    He F; Xia X; Nie D; Yang H; Jiang Y; Huo X; Guo F; Fang B; Hu B; Jiang H; Zhan F; Lv J
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115199. PubMed ID: 32979617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outbreak of COVID-19 infection in children: fear and serenity.
    Pavone P; Ceccarelli M; Taibi R; La Rocca G; Nunnari G
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4572-4575. PubMed ID: 32373997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One size does not fit all - Patterns of vulnerability and resilience in the COVID-19 pandemic and why heterogeneity of disease matters.
    Sominsky L; Walker DW; Spencer SJ
    Brain Behav Immun; 2020 Jul; 87():1-3. PubMed ID: 32205119
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19).
    Kordzadeh-Kermani E; Khalili H; Karimzadeh I
    Future Microbiol; 2020 Sep; 15():1287-1305. PubMed ID: 32851877
    [No Abstract]   [Full Text] [Related]  

  • 25. An increasing public health burden arising from children infected with SARS-CoV2: A systematic review and meta-analysis.
    Zheng B; Wang H; Yu C
    Pediatr Pulmonol; 2020 Dec; 55(12):3487-3496. PubMed ID: 32757374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age and Location in Severity of COVID-19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?
    Root-Bernstein R
    Bioessays; 2020 Nov; 42(11):e2000076. PubMed ID: 32869330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The network effect: studying COVID-19 pathology with the Human Cell Atlas.
    Teichmann S; Regev A
    Nat Rev Mol Cell Biol; 2020 Aug; 21(8):415-416. PubMed ID: 32606379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial and fungal colonization of the respiratory tract in COVID-19 patients should not be neglected.
    Intra J; Sarto C; Beck E; Tiberti N; Leoni V; Brambilla P
    Am J Infect Control; 2020 Sep; 48(9):1130-1131. PubMed ID: 32593810
    [No Abstract]   [Full Text] [Related]  

  • 29. A child with SARS-CoV2-induced croup.
    Tsoi K; Chan KC; Chan L; Mok G; Li AM; Lam HS
    Pediatr Pulmonol; 2021 Jul; 56(7):2377-2378. PubMed ID: 33857338
    [No Abstract]   [Full Text] [Related]  

  • 30. Controversies and challenges with COVID-19 in children: Why are they less susceptible and should they be at home rather than in school?
    Masekela R; Wessels AJ
    Afr J Thorac Crit Care Med; 2020; 26(3):. PubMed ID: 34235426
    [No Abstract]   [Full Text] [Related]  

  • 31. Does melatonin reduce mortality in COVID-19?
    Pilia E; Alborino E; Covello RD
    Ann Med Surg (Lond); 2022 Jun; 78():103817. PubMed ID: 35603098
    [No Abstract]   [Full Text] [Related]  

  • 32. Is coronavirus becoming less deadly?
    Le Page M
    New Sci; 2020 Jul; 247(3291):9. PubMed ID: 33518906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial Light at Night (ALAN): A Potential Anthropogenic Component for the COVID-19 and HCoVs Outbreak.
    Khan ZA; Yumnamcha T; Mondal G; Devi SD; Rajiv C; Labala RK; Sanjita Devi H; Chattoraj A
    Front Endocrinol (Lausanne); 2020; 11():622. PubMed ID: 33013700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor.
    Feitosa EL; Júnior FTDSS; Nery Neto JAO; Matos LFL; Moura MHS; Rosales TO; De Freitas GBL
    Int J Med Sci; 2020; 17(14):2133-2146. PubMed ID: 32922174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and physico-chemical evaluation of melatonin and its solution-state excited properties, with emphasis on its binding with novel coronavirus proteins.
    Al-Zaqri N; Pooventhiran T; Alsalme A; Warad I; John AM; Thomas R
    J Mol Liq; 2020 Nov; 318():114082. PubMed ID: 32863490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention.
    Hussman JP
    Front Pharmacol; 2020; 11():1169. PubMed ID: 32848776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review on Currently Available Potential Therapeutic Options for COVID-19.
    Ohadian Moghadam S
    Int J Gen Med; 2020; 13():443-467. PubMed ID: 32801840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV.
    Nunes MC; Cutland CL; Klugman KP; Madhi SA
    mBio; 2021 Jan; 12(1):. PubMed ID: 33419872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for redetectable positivity in recovered COVID-19 children.
    Peng D; Zhang J; Ji Y; Pan D
    Pediatr Pulmonol; 2020 Dec; 55(12):3602-3609. PubMed ID: 33049115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 infections in children and young people.
    Felsenstein S; Hedrich CM
    Clin Immunol; 2020 Nov; 220():108588. PubMed ID: 32905851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.